Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$7.45B
EV to revenue ratio (TTM)
3.30
EV to ebitda
16.51
Financial Performance
Revenue (TTM)
$3.20B
Gross profit (TTM)
$1.28B
EBITDA
$0.74B
Profitability
Operating margin (TTM)
16.30%
Profit margin
4.17%
Return on assets (TTM)
7.69%
Return on equity (TTM)
70.00%
Per Share Metrics
Revenue per share (TTM)
$9.94
EPS
$0.40
Diluted EPS (TTM)
$0.40
Book value
$1.58
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
53.45
Trailing P/E
53.45
Forward P/E
18.18
PEG ratio
2.02
Price to sales ratio (TTM)
2.33
Price to book ratio (TTM)
13.96
Growth
Quarterly earnings growth (YoY)
10.00%
Quarterly revenue growth (YoY)
157.10%
Analyst Sentiment
Strong buy
3
Buy
4
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.21